Leibniz-Forschungsinstitut für Molekulare Pharmakologie explained
The Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) is a research institute in the Leibniz Association, focussing on proteins as basic structures of cellular organisms. It is one of the large number of research institutions based in Berlin. The institute is situated on a research campus in Buch, a northern district of Berlin. Legally, the FMP and seven other Leibniz Institutes based in Berlin are represented by the Forschungsverbund Berlin (Research Association of Berlin).
The institute has around 270 employees,[1] including researchers and administrative staff.
Research Areas
The Institute focuses on fundamental research in life sciences, with an interdisciplinary approach based on chemistry and biology. The institute is organized into three departments under the broad umbrella of molecular pharmacology:[2]
Collaborations
The institute has many collaborations with national and international universities and research institutes, as well as businesses. Collaboration partners include:
- Free University, Berlin, Germany[3] [4]
- Max Delbrück Center for Molecular Medicine, Berlin, Germany[5] [6]
- European Molecular Biology Laboratory, Heidelberg, Germany[7]
- Hannover Medical School, Hannover, Germany[8]
- University of Potsdam, Potsdam, Germany
- Hospital for Sick Children, Canada
- Université Paris Diderot, France
- INSERM, France
- University of Melbourne, Australia[9] [10]
- University of Geneva, Switzerland[11]
- Schering AG[12]
Funding
The Institute receives core and external funding. The core funding (Grundfinanzierung) is usually split equally between federal and state contributions.[13] In 2012, the institute had a total revenue of 21 million euros, excluding DFG fees.[14]
History
The institute was founded in 1992 as a successor to the "Institut für Wirkstofforschung" (Institute for Active Materials Research, also translated as the Drugs Research Institute), an Institute of the Academy of Sciences of the GDR. The Institut für Wirkstofforschung was founded in 1977 by Peter Oehme, who also served as its first and only director, and had around 230 employees.[15] After the reunification of Germany, scientific institutions underwent a period of readjustment to align those in the former east and west.[16] In 1991, the German Council of Science and Humanities (Wissenschaftsrat) recommended the founding of an institute focused in the area of molecular pharmacology, which led to the establishment of the institute as it is known today.
The institute was originally located in Friedrichsfelde in east Berlin, but moved to its current location in Buch in 2000.Since the founding of the institute, it has been a member of the Leibniz Association. The Institute does not have an official English name, and the acronym "FMP" was used heavily. From 2006, the institute was named Leibniz-Institut für Molekulare Pharmakologie (Leibniz Institute for Molecular Pharmacology), though the institute logo still contained the "FMP" acronym. In May 2017, it was renamed back to "Leibniz-Forschungsinstitut für Molekulare Pharmakologie" (Leibniz Research Institute for Molecular Pharmacology).
Directors of the FMP
External links
52.6243°N 13.5041°W
Notes and References
- Web site: FMP Berlin: About us. www.leibniz-fmp.de. 2019-03-17.
- Web site: FMP Berlin: Research Areas. www.leibniz-fmp.de. 2019-03-17.
- Web site: FMP Berlin: Presynapses come in a packet – Berlin Scientists Identify the Components and Architecture of Neuronal Contact Sites. 2018-08-31. www.leibniz-fmp.de. FMP Berlin. 2019-03-17.
- Web site: FMP Berlin: A protein for learning. 2019-03-04. www.leibniz-fmp.de. FMP Berlin. en. 2019-03-17.
- Web site: FMP Berlin: When Bacteria Build Homes. 2018-05-04. www.leibniz-fmp.de. FMP Berlin. en. 2019-03-17.
- Web site: FMP Berlin: How a Mutated Gene Triggers Hypertension. 2018-04-04. www.leibniz-fmp.de. FMP Berlin. en. 2019-03-17.
- Due. Anne V.. Kuper. Jochen. Geerlof. Arie. Kries. Jens Peter von. Wilmanns. Matthias. 2011-03-01. Bisubstrate specificity in histidine/tryptophan biosynthesis isomerase from Mycobacterium tuberculosis by active site metamorphosis. Proceedings of the National Academy of Sciences. en. 108. 9. 3554–3559. 10.1073/pnas.1015996108. 0027-8424. 3048130. 21321225. 2011PNAS..108.3554D. free.
- Otten. Cécile. Knox. Jessica. Boulday. Gwénola. Eymery. Mathias. Haniszewski. Marta. Neuenschwander. Martin. Radetzki. Silke. Vogt. Ingo. Hähn. Kristina. 2018-09-04. Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations. EMBO Molecular Medicine. 10. 10. e9155. 10.15252/emmm.201809155. 1757-4684. 6180302. 30181117.
- Kesten. Christopher. Wallmann. Arndt. Schneider. René. McFarlane. Heather E.. Diehl. Anne. Khan. Ghazanfar Abbas. van Rossum. Barth-Jan. Lampugnani. Edwin R.. Szymanski. Witold G.. 2019-02-20. The companion of cellulose synthase 1 confers salt tolerance through a Tau-like mechanism in plants. Nature Communications. en. 10. 1. 857. 10.1038/s41467-019-08780-3. 2041-1723. 6382854. 30787279. 2019NatCo..10..857K.
- Web site: FMP Berlin: "Salt Prince" CC1: Newly discovered protein has important function in plants - and could also be important for Alzheimer's research. 2019-02-18. www.leibniz-fmp.de. FMP Berlin. en. 2019-03-17.
- Wang. Haibin. Lo. Wen-Ting. Vujičić Žagar. Andreja. Gulluni. Federico. Lehmann. Martin. Scapozza. Leonardo. Haucke. Volker. Vadas. Oscar. 2018-07-19. Autoregulation of Class II Alpha PI3K Activity by Its Lipid-Binding PX-C2 Domain Module. Molecular Cell. en. 71. 2. 343–351.e4. 10.1016/j.molcel.2018.06.042. 30029007. free.
- Web site: FMP Berlin: Cooperations (Kuehne group). www.leibniz-fmp.de. 2019-03-17.
- Web site: Grundfinanzierung der Forschungseinrichtungen - BuFI Kampagne. Projektträger. Redaktion: DLR. Bundesbericht Forschung und Innovation - BuFI Kampagne. de. 2019-03-17.
- Stellungnahme zum Leibniz-Institut für Molekulare Pharmakologie (FMP) im Forschungsverbund Berlin e. V. 2014-11-27. Evaluation Committee of the Leibniz Association. de, en. 2019-03-17.
- Stellungnahmen zu den außeruniversitären Forschungseinrichtungen in der ehemaligen DDR auf dem Gebiet der Biowissenschaften und der Medizin Institut für Wirkstofforschung (IWF), Berlin. Jul 1991. Wissenschaftsrat. 335/91. 41–49. de. 2019-03-17.
- Web site: East German scientists faced opportunities and disappointment during reunification DW 28.09.2010. www.dw.com. Deutsche Welle. en-GB. 2019-03-17.
- Web site: FMP Berlin: Hartmut Oschkinat - Curriculum Vitae. www.leibniz-fmp.de. 2019-03-17.